About Cdymax (India) Pharma Private Limited
Data last updated: 23 December 2025
Cdymax (India) Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of M/S. Couplet Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 27 October 1994, the company has been in operation for over 32 years.
Registered with ROC Bangalore under CIN U85110KA1994PTC016472.
Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹8.88 Cr. Formerly known as Cdymax (India) Pharma Private Limited and Intermed Labs Private Limited. It is led by directors Santosh Datta Naik and Manorama Avinash.
Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: 116/117 Kiadb Indl Areajigani 2Nd Phase Bangalore, Karnataka, India – 560105.
As per the financials filed for FY 2025, the company reported a revenue of ₹284.85 Cr, a growth of 12% compared to the previous year.
The company has a workforce of approximately 493 employees as per the latest available data. It operates as a subsidiary of M/S. Couplet Limited.
The company is associated with 1 brand - Cdymax. As per MCA filings, the company has open charges of ₹82.98 Cr and satisfied charges of ₹66.47 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cdymax.in.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered Address116/117 Kiadb Indl Areajigani 2Nd Phase Bangalore, Karnataka, India – 560105
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Cdymax (India) Pharma Private Limited
Cdymax (India) Pharma Private Limited has undergone 3 name changes throughout its history. The company was previously known as Cdymax (India) Pharma Private Limited, Intermed Labs Private Limited, and Acebright (India) Pharma Private Limited. The current legal name is Cdymax (India) Pharma Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Cdymax (India) Pharma Private Limited | Current |
| Intermed Labs Private Limited | Previous |
| Acebright (India) Pharma Private Limited | Previous |
CIN History of Cdymax (India) Pharma Private Limited
Cdymax (India) Pharma Private Limited has one previous CIN (Corporate Identification Number): U24231KA1994PTC016472. The current CIN is U85110KA1994PTC016472, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85110KA1994PTC016472 | Current |
| U24231KA1994PTC016472 | Previous |
Associated Brands with Cdymax (India) Pharma Private Limited
Cdymax (India) Pharma Private Limited operates one associated brand: CDYMAX. These brands represent Cdymax (India) Pharma Private Limited's diversified market presence and brand portfolio.
Business Activity of Cdymax (India) Pharma Private Limited
Cdymax (India) Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Cdymax (India) Pharma Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Cdymax (India) Pharma Private Limited
Cdymax (India) Pharma Private Limited is audited by PATIL KABBUR & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PATIL KABBUR & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history for Cdymax (India) Pharma Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Cdymax (India) Pharma Private Limited
Cdymax (India) Pharma Private Limited is currently managed by 2 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Santosh Datta Naik
Also directs:
Cdymax (India) Pharma Private Limited
|
Director | 08 Jan 2024 | 2 Years 7 Months | Current |
|
Manorama Avinash
Also directs:
Arizest Pharma (India) Private Limited, Apple Lifecare (India) Private Limited, Arizestspiro Respicare Private Limited and 1 more
|
Director | 07 May 2011 | 15 Years 3 Months | Current |
Financials of Cdymax (India) Pharma Private Limited FY 2025 filings available
Cdymax (India) Pharma Private Limited reported revenue of ₹284.85 Cr (up 12.00% YoY) for FY 2025.
Ten-year financial statements for Cdymax (India) Pharma Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Cdymax (India) Pharma Private Limited
Shareholding and ownership data for Cdymax (India) Pharma Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Cdymax (India) Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 May 2025 | Others | ₹20 Cr | Open |
| 30 Nov 2021 | Others | ₹5.99 Cr | Open |
| 20 Aug 2020 | Hdfc Bank Limited | ₹45 Cr | Open |
| 03 May 2018 | Others | ₹60 Lakh | Open |
| 03 May 2018 | Others | ₹60 Lakh | Open |
Total charge records: 17 View all charges
Employees and EPFO Compliance at Cdymax (India) Pharma Private Limited
Cdymax (India) Pharma Private Limited has a workforce of 493 employees as of Apr 09, 2024.
Employee and EPFO history for Cdymax (India) Pharma Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Cdymax (India) Pharma Private Limited
GST registrations and filing compliance for Cdymax (India) Pharma Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Cdymax (India) Pharma Private Limited
Credit ratings, litigation, and regulatory alerts for Cdymax (India) Pharma Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Cdymax (India) Pharma Private Limited
MSME payment history for Cdymax (India) Pharma Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Cdymax (India) Pharma Private Limited
Corporate group structure for Cdymax (India) Pharma Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Cdymax (India) Pharma Private Limited
MCA filings and documents for Cdymax (India) Pharma Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Cdymax (India) Pharma Private Limited
Frequently Asked Questions about Cdymax (India) Pharma Private Limited
Cdymax (India) Pharma Private Limited is an active private limited company in the pharma sector based in Bangalore, Karnataka, India. It was incorporated on 27 October 1994 (32+ years old) and is registered under CIN U85110KA1994PTC016472. The company has 493 employees.
Cdymax (India) Pharma Private Limited reported revenue of ₹284.85 Cr for FY 2025 (up 12.00% YoY).
The current directors of Cdymax (India) Pharma Private Limited are:
- Santosh Datta Naik - Director
- Manorama Avinash - Director
The primary industry of Cdymax (India) Pharma Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Cdymax (India) Pharma Private Limited can be reached at the registered office: 116117 Kiadb Indl Areajigani 2Nd Phase Bangalore, Karnataka, India – 560105, or through the website cdymax.in.
The authorised capital is ₹10 Cr, and the paid-up capital is ₹8.88 Cr.